PTEN and acute myeloid leukemia: Furthermore, while a number of specific mutations have been implicated in modulating PTEN in AML (e.g., PML-RARa, NPM1c, and CSK2), the effect on PTEN activity and PTEN protein levels in models utilizing these mutations is not well understood.